GSK Counters Innoviva’s Gonorrhea Hit

 
• By Elizabeth Cairns
  
LONDON- JUNE, 2018: The GlaxoSmithKline headquarters building in Brentford, west London. A British global pharmaceuticals company.

More from Clinical Trials

More from R&D